IL18 and diabetic kidney disease: In streptozotocin-induced diabetic nephropathy rats, chronic pioglitazone treatment reduced renal NFκB, IL-1β and IL-18 levels, depressed the glomerular mesangial expansion, and decreased serum BUN/creatinine [35].